H. van Tinteren

Otto S Hoekstra, Adriaan A Lammertsma, Johan Vansteenkiste, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.

G. Giaccone, E. Smit, C. Ferreira, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical benefit of systemic therapies for recurrent ovarian cancer—ESMO-MCBS scores

H. van Tinteren, A. Reyners, M. Jalving, 2021, ESMO open.

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.

W. M. Smit, M. Hooning, A. Jager, 2020, JAMA oncology.

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial

S. Linn, J. Schellens, H. van Tinteren, 2016, Trials.

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer

J. V. van Sandick, M. V. van Velthuysen, H. van Tinteren, 2010, The British journal of surgery.

Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence.

W. Meinhardt, M. Gallee, H. van Tinteren, 2006, The Journal of urology.

Systematic overview (metaanalysis) of all randomized trials of treatment of prostate cancer

O. Dalesio, H. van Tinteren, H. Tinteren, 1993, Cancer.

Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): The SIOP 2001 experience

M. Carli, K. Pritchard-Jones, H. van Tinteren, 2014, Pediatric blood & cancer.

Upper urinary tract cancer: location is correlated with prognosis.

H. G. van der Poel, H. van Tinteren, S. Horenblas, 2005, European Urology.

Nephroblastoma: does the decrease in tumor volume under preoperative chemotherapy predict the lymph nodes status at surgery?

D. V. von Schweinitz, H. van Tinteren, N. Graf, 2011, Pediatric blood & cancer.

The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium.

P. Snijders, E. Smit, T. Sutedja, 2007, American journal of respiratory and critical care medicine.

Long-term survival data of triple modality treatment of stage IIB–III–IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia – an update

J. van der Zee, P. Koper, L. Prosnitz, 2012, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Incidence and outcomes of patients with late recurrence of Wilms' tumor

K. Pritchard-Jones, J. Dome, H. van Tinteren, 2013, Pediatric blood & cancer.

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

S. Linn, H. van Tinteren, R. Rietbroek, 2022, Breast Cancer Research and Treatment.

Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse

E. Rutgers, H. van Tinteren, M. Stokkel, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients

R. Bernards, C. Caldas, Mariette Schrier, 2019, Clinical Cancer Research.

TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation1

T. Schumacher, H. van Tinteren, T. Schell, 2008, The Journal of Immunology.

Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer.

M. V. van Oijen, C. Punt, M. Koopman, 2017, European journal of cancer.

Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer

O. Hoekstra, E. Smit, P. Postmus, 2003, Thorax.

Is 18F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer?

H. Klomp, H. van Tinteren, R. V. Valdés Olmos, 2010, The Journal of Nuclear Medicine.

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study

E. Strengman, M. Koopman, H. van Tinteren, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer

G. Meijer, E. Bloemena, H. van Tinteren, 2011, Clinical Cancer Research.

Unresectable peritoneal carcinomatosis from colorectal cancer: A single center experience

H. van Tinteren, H. Boot, V. Verwaal, 2011, Journal of surgical oncology.

Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer.

H. Groen, J. Pignon, D. de Ruysscher, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in locally advanced non-small cell lung cancer: a pooled analysis of individual patient data from three randomized trials.

H. Groen, D. de Ruysscher, H. van Tinteren, 2021, Radiotherapy and Oncology.

Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial.

W. V. van Harten, N. Aaronson, K. Sikorska, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

J. V. van Meerbeeck, S. Senan, P. Baas, 2006, British Journal of Cancer.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)

M. Lahaye, J. V. van Sandick, A. Aalbers, 2019, BMC Cancer.

Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non–Small Cell Lung Cancer

H. Klomp, H. van Tinteren, H. Rijna, 2014, The Journal of Nuclear Medicine.

Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer.

M. Verheij, N. van Zandwijk, H. van Tinteren, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

O. Hoekstra, E. Smit, J. Aerts, 2019, British journal of cancer.

The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment.

O. Hoekstra, E. Smit, F. Schramel, 2003, Lung cancer.

FDG-PET in addition to conventional work-up in non-small-cell lung cancer.

O. Hoekstra, E. Smit, H. van Tinteren, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial.

A. Jager, S. Linn, H. van Tinteren, 2014, European journal of cancer.

Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis

R. Boellaard, R. Boellaard, M. Boers, 2012, The Journal of Nuclear Medicine.

Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study

M. Kersten, A. Hagenbeek, H. van Tinteren, 2018, Haematologica.

Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis

P. Nederlof, M. V. van Velthuysen, N. van Zandwijk, 2009, Clinical Cancer Research.

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

H. van Tinteren, H. Tinteren, J. Wagstaff, 1993, British Journal of Cancer.

Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial.

H. Groen, J. Aerts, G. Bootsma, 2021, The Lancet. Respiratory medicine.

Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.

J. Wanders, J. Mcvie, N. van Zandwijk, 1990, Seminars in oncology.

Small cell lung cancer.

O. Dalesio, J. Mcvie, H. van Tinteren, 1988, Acta oncologica.

Prostate‐sparing cystectomy: long‐term oncological results

H. G. van der Poel, W. Meinhardt, H. van Tinteren, 2009, BJU international.

The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis.

P. Ascierto, E. D. de Vries, Douglas B. Johnson, 2021, European journal of cancer.

Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).

K. Pritchard-Jones, I. Leuschner, H. van Tinteren, 2015, European journal of cancer.

Minimally invasive nephrectomy for Wilms tumors in children - data from SIOP 2001.

H. van Tinteren, S. Warmann, J. Fuchs, 2014, Journal of pediatric surgery.

Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.

I. Ora, H. van Tinteren, C. Bergeron, 2007, European journal of cancer.

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

S. Linn, H. van Tinteren, R. Rietbroek, 2022, Breast Cancer Research and Treatment.

The clinical phenotype of YWHAE‐NUTM2B/E positive pediatric clear cell sarcoma of the kidney

R. Pieters, Mio Tanaka, K. Pritchard-Jones, 2016, Genes, chromosomes & cancer.

Indices of body fat distribution and adiposity in Dutch children from birth to 18 years of age.

P. Deurenberg, H. van Tinteren, J. Weststrate, 1989, International journal of obesity.

Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma.

H. van Tinteren, S. Horenblas, O. Nieweg, 2005, The Journal of urology.

Cardiovascular and respiratory complications after major head and neck surgery

A. Balm, H. van Tinteren, N. Antonini, 2006, Head & neck.

Usefulness of indium-111 antimyosin scintigraphy in confirming myocardial injury in patients with anthracycline-associated left ventricular dysfunction.

H. van Tinteren, P. Bruning, R. V. Valdés Olmos, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer.

W. Meinhardt, H. van Tinteren, S. Horenblas, 2004, BJU international.

Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer

W. Meinhardt, H. van Tinteren, S. Horenblas, 2004 .

A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy‐free approach in HER2‐positive metastatic breast cancer: The HAT study (BOOG 2008‐2003), a Dutch Breast Cancer Research Group trial

S. Sleijfer, A. Jager, S. Linn, 2016, Cancer.

p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long‐term follow‐up

H. Peterse, M. Barbareschi, C. Doglioni, 2000 .

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

N. Aaronson, K. Sikorska, K. K. van de Vijver, 2018, The New England journal of medicine.

Bilateral Renal Tumors in Children: The First 5 Years’ Experience of National Centralization in The Netherlands and a Narrative Review of the Literature

J. Drost, R. Kuiper, H. van Tinteren, 2021, Journal of clinical medicine.

Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study group

K. Pritchard-Jones, I. Leuschner, H. van Tinteren, 2011, Pediatric blood & cancer.

Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment

D. de Jong, H. van Tinteren, H. Boot, 2011, Leukemia & lymphoma.

Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.

J. Schornagel, W. Meinhardt, H. van Tinteren, 2005, The Journal of urology.

Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)

A. Broeks, K. Sikorska, E. Rozeman, 2019, Melanoma research.

D. de Ruysscher, E. Smit, D. Ruysscher, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer.

E. Smit, H. van Tinteren, H. Groen, 2007, European journal of cancer.

Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry.

H. Groen, E. Smit, F. Schramel, 2019, Lung cancer.

Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy

H. van Tinteren, G. Janssens, M. Lilien, 2022, Cancers.

Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer.

H. Groen, D. de Ruysscher, H. van Tinteren, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ultrasound‐guided aspiration cytology for the assessment of the clinically N0 neck: Factors influencing its accuracy

L. Smeele, M. V. van Velthuysen, A. Balm, 2008, Head & neck.

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

M. J. van de Vijver, W. V. van Harten, A. Jager, 2022, European journal of cancer.

Predictive value of chromosome 18q11.2‐q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III‐trial AGITG‐MAX

B. Ylstra, C. Punt, H. van Tinteren, 2022, International journal of cancer.

Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor.

H. van Tinteren, B. Taal, J. Bonfrer, 2003, Cancer.

Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy

H. van Tinteren, H. Tinteren, F. Zoetmulder, 2004, The British journal of surgery.

An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.

S. Rodenhuis, H. van Tinteren, J. Kerst, 2013, Urologic oncology.

Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute.

S. Rodenhuis, O. Dalesio, A. V. van Oosterom, 1992, Seminars in oncology.

Cytokeratin subtypes and involucrin in squamous cell carcinoma of the vulva. An immunohistochemical study of 41 cases

W. Mooi, H. van Tinteren, A. Heintz, 1995, Cancer.

Outcome, complications and follow-up in surgically treated squamous cell carcinoma of the vulva 1956-1982.

H. van Tinteren, A. Heintz, A. Ansink, 1991, European journal of obstetrics, gynecology, and reproductive biology.

Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance.

H. van Tinteren, A. Heintz, R. D. de Weger, 1994, Gynecologic oncology.

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?

A. Bergman, H. van Tinteren, R. Meijer, 2012, The Journal of urology.

Survival after cystectomy for invasive bladder cancer.

H. van Tinteren, S. Horenblas, J. Nieuwenhuijzen, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

D. de Ruysscher, J. Praag, H. van Tinteren, 2019, Acta oncologica.

Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy.

H. van Tinteren, N. Graf, C. Bergeron, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N. Aaronson, J. V. van Sandick, H. van Tinteren, 2010, The Journal of thoracic and cardiovascular surgery.

IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer.

M. Verheij, H. van Tinteren, H. Boot, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A comparison of physical examination and imaging in determining the extent of primary penile carcinoma

M. Gallee, H. van Tinteren, S. Horenblas, 2003, BJU international.

Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

L. Moonen, H. van Tinteren, S. Horenblas, 1993, The Journal of urology.

Squamous cell carcinoma of the penis. II. Treatment of the primary tumor.

L. Moonen, H. van Tinteren, S. Horenblas, 1992, The Journal of urology.

Field block: an additional technique of potential value for breast surgery under general anaesthesia.

H. Oldenburg, H. van Tinteren, E. Rutgers, 2008, European journal of anaesthesiology.

Evaluation of boost irradiation in patients with intermediate‐risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP‐WT‐2001 Registry

C. Rübe, K. Pritchard-Jones, H. van Tinteren, 2018, Pediatric blood & cancer.

Iron deficiency anaemia in hospitalised patients: value of various laboratory parameters. Differentiation between IDA and ACD.

H. van Tinteren, J. Kuenen, W. Vasmel, 2001, The Netherlands journal of medicine.

Risk factors for the development of oesophageal cancer as a second primary tumour.

H. van Tinteren, B. Taal, F. E. van Leeuwen, 1995, European journal of cancer.

Short-Term Outcome after Cystectomy: Comparison of Two Different Perioperative Protocols

H. G. van der Poel, W. Meinhardt, H. van Tinteren, 2012, Urologia Internationalis.

Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela

E. Rutgers, H. Peterse, L. Strobbe, 2004, Breast Cancer Research and Treatment.

Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy.

H. G. van der Poel, W. Meinhardt, H. van Tinteren, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: results of a compassionate use program in The Netherlands

J. Verweij, J. Beijnen, W. W. ten Bokkel Huinink, 2000, Anti-Cancer Drugs.

Scintigraphic assessment of salivary function and excretion response in radiation‐induced injury of the major salivary glands

F. Hilgers, A. Balm, H. van Tinteren, 1994, Cancer.

p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up.

H. Peterse, M. Barbareschi, C. Doglioni, 2000, International journal of cancer.

A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients.

G. Giaccone, E. Smit, P. Postmus, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology.

D. Newling, M. Gallee, H. van Tinteren, 1994, Urology.

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

T. Wiggers, H. van Tinteren, H. Tinteren, 2001, British Journal of Cancer.

Adjuvant treatment in colorectal cancer

H. van Tinteren, B. Taal, L. J. van ‘t Veer, 2002, British Journal of Cancer.

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

H. van Tinteren, H. Tinteren, P. Huijgens, 1999, Journal of clinical pathology.

Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).

D. de Ruysscher, J. V. van Meerbeeck, K. Sikorska, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Outcome of patients with primary central nervous system lymphoma treated outside clinical trials.

A. Hart, M. Kersten, D. de Jong, 2014, Netherlands Journal of Medicine.

Optimization of intradermal vaccination by DNA tattooing in human skin.

T. Schumacher, J. Beijnen, W. Hennink, 2008, Human gene therapy.

Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments

A. van Oudenaarden, H. Horlings, L. Kester, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

W. V. van Harten, T. Schumacher, J. Beijnen, 2022, The New England journal of medicine.

Evidence for a delay in diagnosis of Wilms’ tumour in the UK compared with Germany: implications for primary care for children

A. Craft, K. Pritchard-Jones, H. van Tinteren, 2016, Archives of Disease in Childhood.

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.

E. Smit, C. Faivre-Finn, S. Senan, 2017, Lung cancer.

Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial.

K. Pritchard-Jones, H. van Tinteren, G. Vujanić, 2019, European journal of cancer.

Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial

H. van Tinteren, M. Powis, R. Squire, 2019, Pediatric blood & cancer.

Acoustic analysis of the voiced-voiceless distinction in Dutch tracheoesophageal speech.

L. Pols, H. van Tinteren, P. Jongmans, 2010, Journal of speech, language, and hearing research : JSLHR.

Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

H. van Tinteren, H. Boot, F. Zoetmulder, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single Institution's experience with consistent application of provox indwelling voice prostheses.

F. Hilgers, A. Balm, H. van Tinteren, 2000, Archives of otolaryngology--head & neck surgery.

Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy.

M. Gallee, H. van Tinteren, S. Horenblas, 2003, The Journal of urology.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

H. Horlings, L. Wessels, T. Schumacher, 2019, Nature Medicine.

Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine-based anticancer regimens in daily clinical care.

J. Schellens, J. Beijnen, A. Huitema, 2016, European journal of cancer.

99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy

F. Hoebers, M. V. van Herk, C. Rasch, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study

M. O'sullivan, D. Gisselsson, M. Kool, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma

A. E. Hoetink, A. Bel, J. Merks, 2022, Cancers.

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy

M. J. van de Vijver, S. Rodenhuis, P. Kristel, 2006, British Journal of Cancer.

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

M. J. van de Vijver, S. Rodenhuis, M. Hauptmann, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment

P. V. van Diest, R. Michalides, A. Balkenende, 2002, British Journal of Cancer.

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

M. J. van de Vijver, J. Peterse, P. Devilee, 1992, Cancer research.

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

R. Versteeg, H. Caron, J. Koster, 2023, Frontiers in Oncology.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

H. Horlings, T. Schumacher, L. Wessels, 2019, Nature Medicine.

Vemurafenib for BRAF V600 mutated advanced melanoma: results of treatment beyond progression.

C. Blank, J. Haanen, H. van Tinteren, 2015, European journal of cancer.

Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.

H. Horlings, A. Broeks, Z. Trajanoski, 2020, European journal of cancer.

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

S. Rodenhuis, M. Hauptmann, L. Wessels, 2014, Breast Cancer Research.

Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.

Eckart Meese, Andreas Keller, Roland Eils, 2015, Cancer cell.

Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer.

H. Klomp, J. Burgers, H. van Tinteren, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30‐year SIOP‐RTSG experience

R. Kuiper, K. Pritchard-Jones, H. van Tinteren, 2020, Cancer.

Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?

H. van Tinteren, B. Slotman, 2015, Translational lung cancer research.

Overall survival and PD‐L1 expression in metastasized malignant melanoma

H. V. van Boven, C. Blank, H. van Tinteren, 2011, Cancer.

A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.

J. Peterse, R. Michalides, E. Wientjens, 1996, British Journal of Cancer.

Long-term impact of the 70-gene signature on breast cancer outcome

M. J. van de Vijver, R. Bernards, L. J. Veer, 2014, Breast Cancer Research and Treatment.

Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001

K. Pritchard-Jones, H. van Tinteren, H. Tinteren, 2019, PloS one.

Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.

Norbert Graf, Jens-Peter Schenk, H. van Tinteren, 2012, European journal of cancer.

Stromal and epithelial predominant Wilms tumours have an excellent outcome: The SIOP 93 01 experience

H. van Tinteren, G. Vujanić, B. Sandstedt, 2010, Pediatric blood & cancer.

Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature

C. Rübe, J. Drost, H. van Tinteren, 2021, Cancers.

Outcome after surgical resections of recurrent chest wall sarcomas.

F. van Coevorden, H. Klomp, M. Wouters, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration‐resistant prostate cancer who progress after docetaxel and abiraterone treatment

A. Bergman, H. van Tinteren, M. Los, 2014, Cancer.

Monitoring Response to Antiangiogenic Therapy in Non–Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI

Pieter Leffers, Mark Lubberink, Otto S Hoekstra, 2011, The Journal of Nuclear Medicine.

Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR

K. Sikorska, C. Blank, M. Lahaye, 2021, Annals of surgery.

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

K. Shannon, A. Broeks, T. Schumacher, 2019, The Lancet. Oncology.

High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

S. Rodenhuis, M. Nooij, E. D. de Vries, 2003, The New England journal of medicine.

Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system.

H. van Tinteren, S. Horenblas, H. Tinteren, 1994, The Journal of urology.

Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology.

L. Moonen, H. van Tinteren, S. Horenblas, 1991, The Journal of urology.

Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.

J. Schellens, H. Rosing, J. Beijnen, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.

E. Jassem, N. van Zandwijk, W. Mooi, 1992, Seminars in oncology.

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging.

J. Marcus, O. Hoekstra, E. Smit, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study

P. Nederlof, A. Meindl, E. Gross, 2016, BMC Cancer.

Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial.

H. Putter, C. V. D. van de Velde, K. Sikorska, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.

N. Vogelzang, H. van Tinteren, M. Soloway, 1992, The Journal of urology.

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.

M. J. van de Vijver, S. Linn, D. Nuyten, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Predicting Early Failure after Adjuvant Chemotherapy in High-Risk Breast Cancer Patients with Extensive Lymph Node Involvement

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2004, Clinical Cancer Research.

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up.

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Views on Acton et al's “Investigation of tracheoesophageal voice prosthesis leakage patterns: Patient's self‐report versus clinician's confirmation”

H. van Tinteren, F. Hilgers, M. V. D. van den Brekel, 2008, Head & neck.

Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)

P. Nederlof, S. Linn, M. Kok, 2021, Breast Care.

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

H. Groen, H. van Tinteren, C. U. Uyl‐de Groot, 2019, OncoTargets and therapy.

Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year’s experience of national centralization

H. Karim-Kos, J. Drost, R. Kuiper, 2022, PLoS ONE.

Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93‐01, 2001 and UK‐IMPORT database: A report of the SIOP‐Renal Tumor Study Group

M. Gessler, K. Pritchard-Jones, D. Murphy, 2021, International journal of cancer.

Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP).

C. Rübe, M. Gessler, K. Pritchard-Jones, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 study.

K. Pritchard-Jones, H. van Tinteren, N. Graf, 2012, European journal of cancer.

On the Role of Melanoma-Specific CD8+ T-Cell Immunity in Disease Progression of Advanced-Stage Melanoma Patients

T. Schumacher, J. Haanen, M. Gallee, 2004, Clinical Cancer Research.

Multiple mechanisms of MYCN dysregulation in Wilms tumour

D. Gisselsson, M. Kool, M. Gessler, 2015, Oncotarget.

Incidence and survival of paediatric renal tumours in the Netherlands between 1990 and 2014.

H. Karim-Kos, H. van Tinteren, M. Wijnen, 2022, European journal of cancer.

Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores.

C. Sessa, H. van Tinteren, A. Reyners, 2018, Cancer treatment reviews.

Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.

N Graf, R. Pieters, I. Leuschner, 2013, European journal of cancer.

International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study

K. Pritchard-Jones, H. van Tinteren, J. Brok, 2022, JCO global oncology.

Is radiotherapy required in first‐line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP‐RTSG, AIEOP, JWiTS, and UKCCSG

C. Rübe, N. Sebire, K. Pritchard-Jones, 2019, Pediatric blood & cancer.

Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer

A. Harris, A. Shvarts, P. Groep, 2005, Journal of Clinical Pathology.

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

J. Wesseling, H. van Tinteren, E. Rutgers, 2013, International journal of cancer.

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG.

C. Seynaeve, J. Nortier, H. van Tinteren, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

H. Putter, C. V. D. van de Velde, K. Sikorska, 2018, The Lancet. Oncology.

Resection of secondary pulmonary malignancies in head and neck cancer patients

H. Klomp, H. van Tinteren, S. Burgers, 2010, The Journal of Laryngology & Otology.

Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer

H. Klomp, M. V. van Velthuysen, N. van Zandwijk, 2009, Head & neck.

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.

O. Dalesio, U. Pastorino, N. de Vries, 2000, Journal of the National Cancer Institute.

A Randomized Phase II Study Adding Axitinib to Pemetrexed‐Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single‐Center Trial Combining Clinical and Translational Outcomes

P. Baas, A. Griffioen, H. van Tinteren, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments

A. Oudenaarden, A. van Oudenaarden, H. Horlings, 2021, Clinical Cancer Research.

Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04).

S. Linn, M. Kok, J. Wesseling, 2018, European journal of cancer.

A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situ.

C. Blank, W. Meinhardt, J. Haanen, 2011, Urology.

Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival.

L. Moonen, M. Gallee, H. van Tinteren, 2007, The Journal of urology.

Intracranial relapse in Wilms tumor patients

H. van Tinteren, N. Graf, B. Sandstedt, 2004, Pediatric blood & cancer.

Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

A. Huitema, H. van Tinteren, S. Nierkens, 2021, Blood advances.

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

M. Kersten, A. Hagenbeek, D. de Jong, 2020, Haematologica.

Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia

C. Zwaan, H. van Tinteren, P. Bader, 2022, Leukemia.

EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.

J. Westerga, J. Schellens, J. Beijnen, 2016, Neuro-oncology.

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

H. Horlings, L. Wessels, S. Linn, 2019, Nature Medicine.

Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups

K. Pritchard-Jones, C. Patte, P. Grundy, 2008, Pediatric blood & cancer.

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study

K. Pritchard-Jones, I. Leuschner, H. van Tinteren, 2014, British Journal of Cancer.

Carcinoid heart disease

H. van Tinteren, B. Taal, Harm van Tinteren, 2003, The New England journal of medicine.

Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment

H. Klomp, N. van Zandwijk, H. van Tinteren, 2010, Ecancermedicalscience.

Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil.

E. Voest, A. Huitema, H. van Tinteren, 2015, JAMA oncology.

The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool

A. Verbeek, G. D. den Heeten, H. Zonderland, 2012, European Radiology.

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

W. V. van Harten, L. J. Veer, S. Linn, 2014, Breast Cancer Research and Treatment.

Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer.

Marie-Christine W. Gast, P. Span, J. Schellens, 2011, Journal of cancer research and clinical oncology.

Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients

Marie-Christine W. Gast, S. Rodenhuis, P. Span, 2008, BMC Cancer.

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients.

P. Baas, N. van Zandwijk, H. van Tinteren, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Sleep Endoscopy Versus Modified Mallampati Score in Sleep Apnea and Snoring

N. de Vries, H. van Tinteren, C. den Herder, 2005, The Laryngoscope.

Hyoidthyroidpexia: A Surgical Treatment for Sleep Apnea Syndrome

N. de Vries, H. van Tinteren, Harm van Tinteren, 2005, The Laryngoscope.

Prospective cost-effectiveness analysis of genomic profiling in breast cancer.

W. V. van Harten, S. Linn, J. Bueno-de-Mesquita, 2013, European journal of cancer.

Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.

H. Groen, M. Boers, O. Hoekstra, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre- and post-radiotherapy computed tomography in laryngeal cancer: imaging-based prediction of local failure.

S. Stringer, W. Mendenhall, R. Hermans, 1999, International journal of radiation oncology, biology, physics.

Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

A. Jager, H. van Tinteren, N. Nota, 2016, Clinical Cancer Research.

FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC.

H. Klomp, H. van Tinteren, R. V. Valdés Olmos, 2014, World journal of radiology.

18F-Fluorodeoxyglucose Positron Emission Tomography versus Computed Tomography in Predicting Histopathological Response to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Treatment in Resectable Non-Small Cell Lung Cancer

H. Klomp, H. van Tinteren, H. Rijna, 2014, Annals of Surgical Oncology.

Treatment of myogenic temporomandibular disorder: a prospective randomized clinical trial, comparing a mechanical stretching device (TheraBite®) with standard physical therapy exercise

L. van der Molen, L. Smeele, F. Hilgers, 2014, Cranio : the journal of craniomandibular practice.

Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG)

G. Kazemier, G. Meijer, C. Punt, 2015, BMC Cancer.

Loss of reirradiation tolerance in the kidney with increasing time after single or fractionated partial tolerance doses.

F. Stewart, H. van Tinteren, H. Tinteren, 1994, International journal of radiation biology.

Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.

H. Groen, D. de Ruysscher, E. Smit, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancer

J. Nortier, H. van Tinteren, J. Vermorken, 2000, Breast Cancer Research and Treatment.

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.

C. Seynaeve, J. Nortier, H. van Tinteren, 2014, Breast.

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

H. Horlings, T. Schumacher, L. Wessels, 2019, Nature Medicine.

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

J. Schellens, J. Beijnen, J. Schellens, 2014, British Journal of Cancer.

Extended Continuous Oral Temozolomide in Patients with Progressive Metastatic Renal Cell Carcinoma Not Responding to Interferon Alpha 2b

H. van Tinteren, S. Horenblas, A. Bex, 2005, Journal of chemotherapy.

Mitoxantrone and GM-CSF: a phase I study with an escalated dose of mitoxantrone in breast cancer.

S. Rodenhuis, O. Dalesio, H. van Tinteren, 1992, Pathologie-biologie.

Validity of Simplified 3′-Deoxy-3′-[18F]Fluorothymidine Uptake Measures for Monitoring Response to Chemotherapy in Locally Advanced Breast Cancer

M. Lubberink, A. Lammertsma, O. Hoekstra, 2012, Molecular Imaging and Biology.

Surgical treatment of locally recurrent rectal cancer.

H. van Tinteren, H. Tinteren, F. Zoetmulder, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography.

M. Boers, O. Hoekstra, E. Smit, 2001, Controlled clinical trials.

Evaluation of Cost-effectiveness of FDG-PET in Non-Small Cell Lung Cancer.

O. Hoekstra, E. Smit, H. van Tinteren, 2006, PET clinics.

Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.

C. Rübe, J. Drost, C. Morosi, 2022, European journal of cancer.

Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)

H. van Tinteren, G. Vujanić, N. Graf, 2014, Pediatric blood & cancer.

Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer.

H. Rosing, J. Beijnen, J. Schellens, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Nursing care for oral complications associated with chemotherapy: A survey among members of the Dutch Oncology Nursing Society

H. van Tinteren, R. Nieweg, E. K. Poelhuis, 1992, Cancer nursing.

Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.

E. Jassem, N. van Zandwijk, H. van Tinteren, 1990, European journal of cancer.

Cognitive and Behavioral Development of 9-Year-Old Children After Maternal Cancer During Pregnancy: A Prospective Multicenter Cohort Study

L. Lagae, Camilla Fontana, M. Fumagalli, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Repeatability of Metabolically Active Volume Measurements with 18F-FDG and 18F-FLT PET in Non–Small Cell Lung Cancer

Ronald Boellaard, Otto S Hoekstra, Virginie Frings, 2010, The Journal of Nuclear Medicine.

P. Nederlof, A. Meindl, E. Gross, 2016, BMC Cancer.

Implementation of endoscopic ultrasound for lung cancer staging.

K. Rabe, O. Dekkers, J. Annema, 2010, Gastrointestinal endoscopy.

Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature—A report from the SIOP Renal Tumor Study Group

K. Pritchard-Jones, H. van Tinteren, J. Brok, 2018, Pediatric blood & cancer.

Locoregional control using highly conformal flank target volumes and Volumetric-Modulated Arc Therapy in pediatric renal tumors: results from the Dutch national cohort.

H. van Tinteren, G. Janssens, M. Wijnen, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.

S. Rodenhuis, M. Nooij, C. Seynaeve, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Added Value of Baseline 18F-FDG Uptake in Serial 18F-FDG PET for Evaluation of Response of Solid Extracerebral Tumors to Systemic Cytotoxic Neoadjuvant Treatment: A Meta-Analysis

I. Riphagen, O. Hoekstra, S. Stroobants, 2010, The Journal of Nuclear Medicine.

A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO‐101 in Patients With Advanced Solid Tumors

J. Schellens, H. Rosing, J. Beijnen, 2013, Journal of clinical pharmacology.

C. Seynaeve, J. Nortier, H. van Tinteren, 2014 .

Evaluating mobility for radiotherapy planning of lung tumors: a comparison of virtual fluoroscopy and 4DCT.

Suresh Senan, Ben J Slotman, Frank J Lagerwaard, 2006, Lung cancer.

ITCC-101/APAL2020D: A Randomized Phase 3 Trial of Fludarabine/Cytarabine/Gemtuzumab Ozogamycin with or without Venetoclax in Children with Relapsed Acute Myeloid Leukemia

D. Reinhardt, H. van Tinteren, S. Karol, 2022, Blood.

A joint international consensus statement for measuring quality of survival for patients with childhood cancer

F. Aarsen, D. Mulrooney, D. Green, 2023, Nature Medicine.

CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasone.

E. Smit, T. Sutedja, P. Postmus, 2008, Lung cancer.

Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.

W. M. Smit, S. Rodenhuis, N. Aaronson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of endometrial cancer after tamoxifen treatment of breast cancer

J. Willem, L. Schouten, F. V. van Leeuwen, 1994, The Lancet.

Impact of the COVID‐19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group study

H. Karim-Kos, K. Pritchard-Jones, H. van Tinteren, 2023, Cancer medicine.

Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.

R. Boellaard, O. Hoekstra, H. van Tinteren, 2010, European journal of cancer.

Response to the letter to the editor: 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk satisfaction in the SIOP2009/Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) trial

R. Pieters, R. Williams, K. Pritchard-Jones, 2015, Genes, chromosomes & cancer.

A Randomized Phase II Study Adding Axitinib to Pemetrexed‐Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single‐Center Trial Combining Clinical and Translational Outcomes

P. Baas, A. Griffioen, H. van Tinteren, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

M. J. van de Vijver, J. Peterse, D. Atsma, 2007, The Lancet. Oncology.

Radiologic versus Segmentation Measurements to Quantify Wilms Tumor Volume on MRI in Pediatric Patients

H. van Tinteren, M. Wijnen, M. V. D. van den Heuvel-Eibrink, 2023, Cancers.

N. Aaronson, J. V. van Sandick, H. van Tinteren, 2010, The Journal of thoracic and cardiovascular surgery.

Carcinoid heart disease

H. van Tinteren, B. Taal, J. Bonfrer, 2003, Cancer.

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

F. van Coevorden, K. Sikorska, J. V. van Sandick, 2018, The Lancet. Oncology.

Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.

W. M. Smit, S. Rodenhuis, N. Aaronson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

R. Bernards, C. Caldas, Mariette Schrier, 2019, Clinical Cancer Research.

Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.

W. Oyen, M. Boers, O. Hoekstra, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.

R. Boellaard, O. Hoekstra, H. van Tinteren, 2010, European journal of cancer.

Dynamic Sentinel Node Biopsy in Penile Carcinoma: Evaluation of 10 Years Experience

W. Meinhardt, H. van Tinteren, S. Horenblas, 2006 .

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.

E. Smit, C. Faivre-Finn, S. Senan, 2017, Lung cancer.

Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non–Small Cell Lung Cancer

H. Klomp, H. van Tinteren, E. Schaake, 2014, The Journal of Nuclear Medicine.

Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.

R. Eils, M. O'sullivan, M. Kool, 2015, Cancer cell.

Implementation of endoscopic ultrasound for lung cancer staging.

K. Rabe, O. Dekkers, J. Annema, 2010, Gastrointestinal endoscopy.

Ultrasound‐guided aspiration cytology for the assessment of the clinically N0 neck: Factors influencing its accuracy

L. Smeele, A. Balm, H. van Tinteren, 2008, Head & neck.

Reaction on the Interpretation of the Hippocampus Avoidance Prophylactic Cranial Irradiation Trial in SCLC (NCT01780675).

D. de Ruysscher, J. V. van Meerbeeck, K. Sikorska, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?

D. de Ruysscher, J. V. van Meerbeeck, K. Sikorska, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.

N. S. van den Berg, H. van Tinteren, B. V. van Rhijn, 2014, European urology.